Ward 86 shares *updated* clinical considerations and recommendations for starting patients on CAB/RPV LA therapy
(2023 Update) RAPID Provider Detailing Brochure “Rapid ART: Immediate ART initiation at HIV diagnosis and re-engagement in care”
March 13, 2023Ward 86 shares *updated* clinical considerations and recommendations for starting patients on CAB/RPV LA therapy
Ward 86, established in January 1983, is a large HIV clinic based at San Francisco General Hospital at the University of California, San Francisco (UCSF). Ward 86 serves a publicly-insured and underinsured population of people with HIV and those at risk of HIV in the city of San Francisco.
Purpose of this protocol
- Provide guidance to clinicians on long-acting injectable cabotegravir/rilpivirine (CAB/RPV LA) for their patients
- Establish a workflow for referral, initiation, and management of patients starting CAB/RPV LA
- Provide guidance to clinicians on education to patients who will receive CAB/RPV LA
- Provide guidance on care coordination, including clinic appointments and follow-ups, for patients on CAB/RPV LA
Here is a link to the updated full-text protocol: https://gettingtozerosf.org/wp-content/uploads/2023/05/Ward-86-LAI-ART-Protocol-4-2023.pdf (April 2023)
This is a resource that can be adapted to your city or jurisdiction’s needs.
Please email contact@gettingtozerosf.org if you have questions for the Ward 86 HIV Clinic or the Co-Chair of the GTZ-RAPID Committee Dr. Susa Coffey (susa.coffey@ucsf.edu).
